Predictors of Receiving Surgical Treatment for Neovascular Glaucoma in the California Medicare Population
Journal of Clinical & Translational Ophthalmology · 08.06.2026 · 4 (2) · 15
DOI: 10.3390/jcto4020015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical & Translational Ophthalmology, online erschienen am 08.06.2026. Verfasst von Justin S. Yun und 4 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research to Prevent Blindness, Research to Prevent Blindness Career Development Award, American Glaucoma Society Mid Career Physician Scientist Award.
Abstract (Originalsprache)
Background
Population-level predictors of intraocular pressure (IOP)-lowering surgery for neovascular glaucoma (NVG) are understudied. This study examines factors associated with IOP-lowering surgery in California (CA) Medicare beneficiaries with NVG.
Methods
The study population included all 2019 CA Medicare beneficiaries with NVG. Covariates included age, sex, race/ethnicity, history of treatments for retinal ischemia, dual Medicare/Medicaid eligibility, Social Vulnerability Index score, and Charlson Comorbidity Index (CCI) score. Outcomes included incidence of trabeculectomy, tube shunt, minimally invasive glaucoma surgery, cyclophotocoagulation (CPC), or any IOP-lowering surgery.
Results
Of 1843 beneficiaries, 264 (14.3%) had IOP-lowering surgeries. In multivariable logistic regression including all covariates, CCI ≥ 5 versus 0 was associated with lower odds of any IOP-lowering surgery and of each type of surgery except CPC (adjusted odds ratio [aOR] = 0.47, 95% confidence interval [CI] = 0.29, 0.75 for any versus no surgery; aOR = 1.35, CI = 0.51, 3.60 for CPC). Compared to Non-Hispanic White, racial and ethnic minorities had increased odds of trabeculectomy (aOR = 3.77, CI = 1.05, 13.57 for Black; aOR = 2.69, CI = 1.04, 6.92 for Hispanic) and tube shunt (aOR = 2.62, CI = 1.27, 5.41 for Other/Unknown). Beneficiaries 75–79 versus 65–69 years old had decreased odds of trabeculectomy (aOR = 0.21, CI = 0.05, 0.98).
Conclusions
Among CA Medicare beneficiaries, higher systemic disease burden was associated with a decreased likelihood of surgery for NVG, while racial and ethnic minorities were more likely to undergo certain procedures. These findings suggest surgical risk stratification and treatment pattern disparities for individuals with NVG.
Förderung
- Research to Prevent Blindness
- Research to Prevent Blindness Career Development Award
- American Glaucoma Society Mid Career Physician Scientist Award
Zitieren
APA
Yun, J. S., Kitayama, K., Pan, D., Yu, F., & Tseng, V. L. (2026). Predictors of Receiving Surgical Treatment for Neovascular Glaucoma in the California Medicare Population. Journal of Clinical & Translational Ophthalmology, 4(2), 15. https://doi.org/10.3390/jcto4020015
Vancouver
Yun JS, Kitayama K, Pan D, Yu F, Tseng VL. Predictors of Receiving Surgical Treatment for Neovascular Glaucoma in the California Medicare Population. Journal of Clinical & Translational Ophthalmology. 2026;4(2):15. doi:10.3390/jcto4020015
BibTeX
@article{Yun2026,
author = {Yun, Justin S. and Kitayama, Ken and Pan, Deyu and Yu, Fei and Tseng, Victoria L.},
title = {Predictors of Receiving Surgical Treatment for Neovascular Glaucoma in the California Medicare Population},
journal = {Journal of Clinical & Translational Ophthalmology},
year = {2026},
volume = {4},
number = {2},
pages = {15},
doi = {10.3390/jcto4020015}
}
EUVIMED